Professional Documents
Culture Documents
Outpatient Psychotherapy
for Borderline Personality Disorder
Randomized Trial of Schema-Focused Therapy
vs Transference-Focused Psychotherapy
Josephine Giesen-Bloo, MSc; Richard van Dyck, MD, PhD; Philip Spinhoven, PhD; Willem van Tilburg, MD, PhD;
Carmen Dirksen, PhD; Thea van Asselt, MSc; Ismay Kremers, PhD; Marjon Nadort, MSc; Arnoud Arntz, PhD
Context: Borderline personality disorder is a severe and Results: Data on 44 SFT patients and 42 TFP patients
chronic psychiatric condition, prevalent throughout health were available. The sociodemographic and clinical char-
care settings. Only limited effects of current treatments acteristics of the groups were similar at baseline. Sur-
have been documented. vival analyses revealed a higher dropout risk for TFP
patients than for SFT patients (P=.01). Using an intention-
Objective: To compare the effectiveness of schema- to-treat approach, statistically and clinically significant
focused therapy (SFT) and psychodynamically based improvements were found for both treatments on all mea-
transference-focused psychotherapy (TFP) in patients with sures after 1-, 2-, and 3-year treatment periods. After 3
borderline personality disorder. years of treatment, survival analyses demonstrated that
significantly more SFT patients recovered (relative
Design: A multicenter, randomized, 2-group design. risk=2.18; P=.04) or showed reliable clinical improve-
ment (relative risk=2.33; P=.009) on the Borderline Per-
Setting: Four general community mental health centers. sonality Disorder Severity Index, fourth version. Robust
analysis of covariance (ANCOVA) showed that they also
Participants: Eighty-eight patients with a Borderline Per- improved more in general psychopathologic dysfunc-
sonality Disorder Severity Index, fourth version, score tion and measures of SFT/TFP personality concepts
greater than a predetermined cutoff score. (P⬍.001). Finally, SFT patients showed greater in-
creases in quality of life than TFP patients (robust
Intervention: Three years of either SFT or TFP with ANCOVAs, P=.03 and P⬍.001).
sessions twice a week.
Conclusions: Three years of SFT or TFP proved to be ef-
Main Outcome Measures: Borderline Personality Dis- fective in reducing borderline personality disorder–
order Severity Index, fourth version, score; quality of life; specific and general psychopathologic dysfunction and
general psychopathologic dysfunction; and measures of measures of SFT/TFP concepts and in improving quality
SFT/TFP personality concepts. Patient assessments were of life; SFT is more effective than TFP for all measures.
made before randomization and then every 3 months for
3 years. Arch Gen Psychiatry. 2006;63:649-658
B
ORDERLINE PERSONALITY DIS- randomized clinical trials of patients with
order (BPD) is marked by BPD, as manifested by good treatment re-
chronicinstabilityinmultiple tention and reduced suicide attempts, acts
areas (ie, emotional dysregu- of self-harm, and hospitalizations. How-
lation,self-harm,impulsivity, ever, no pharmacologic or psychosocial
and identity disturbance). The prevalence treatment has demonstrated efficacy for all
of BPD is estimated to be 1% to 2.5% in the aspects of BPD, such as affective, identity,
general population and 10% to 50% in psy- and interpersonal disturbances.12
chiatric outpatient and inpatient settings.1 We compared the effectiveness of 2 pro-
The medical and other societal costs of BPD longed outpatient treatments that aim at
are substantial2 (also T.V.A., C.D., A.A., and achieving full recovery from BPD: schema-
Johannis Severens, PhD, unpublished data, focused therapy (SFT)13-15 and transfer-
September 2005). Suicide risk is estimated ence-focused psychotherapy (TFP).16,17
to be up to 10%.3 A few treatments— Schema-focused therapy is an integrative
outpatientdialecticalbehaviortherapy4-8 and cognitive therapy, and TFP is a psycho-
Author Affiliations are listed at psychoanalytically oriented treatments9-11— dynamically based psychotherapy. Both
the end of this article. have demonstrated some effectiveness in treatments intend to bring about a struc-
1.0
85 Patients Excluded
40 Declined Participation
24 Did Not Meet Inclusion Criteria 0.9 SFT
19 Met Exclusion Criteria
2 Had Insufficient Availability 0.8
0.7
88 Randomized
Proportion of Patients
TFP
0.6
45 Patients Allocated to SFT 43 Patients Allocated to TFP
0.5
12 Lost to Therapy and Assessments 22 Lost to Therapy and Assessments
2 Between 6 and 9 mo 8 Between 0 and 3 mo 0.4
1 Between 9 and 12 mo 3 Between 3 and 6 mo
2 Between 12 and 15 mo 1 Between 6 and 9 mo
3 Between 18 and 21 mo 4 Between 9 and 12 mo 0.3
2 Between 27 and 30 mo 4 Between 18 and 21 mo
2 Between 30 and 33 mo 1 Between 24 and 27 mo
0.2
1 Between 27 and 30 mo
Reasons
6 Had No Faith in SFT or Therapist Reasons
0.1
2 Because of SFT Limit Setting 10 Had No Faith in TFP or Therapist
2 For Psychotic Decompensation 4 Considered Themselves
(1 Patient Was Falsely Included, Recovered
Earlier Psychoses Overseen) 3 For TFP Contract Breech 0 200 400 600 800 1000 1200
1 For Deteriorating Somatic 2 For No TFP Contract Reached Duration of Therapy, d
Condition at Start
1 Considered Herself Recovered 1 Was Untraceable, Never Started
1 Had a Contraindication at
Therapist Evaluation
Figure 2. Proportion of patients undergoing transference-focused
1 Unknown psychotherapy (TFP) and schema-focused therapy (SFT).
PATIENT ACCRUAL
44 Included in Analyses (1 Patient 42 Included in Analyses (1 Patient
Excluded Owing to Unreliable Excluded Because Untraceable
Assessments Due to Increased After Randomization; Never Met The study was conducted between September 1, 1999,
Blindness) or Spoke to Therapist) and April 30, 2004. Patient flow is presented in Figure 1.
Of 173 patients referred to the study centers, 40 (23.1%)
Figure 1. Patient flow in the randomized controlled trial. SFT indicates
declined participation (12 patients after initial contact
schema-focused therapy; TFP, transference-focused psychotherapy. and 28 after having 1 or more appointments in the screen-
ing procedure). Another 45 patients (26.0%) were not
after the start of treatment, with treatment group as the covar- eligible for participation: 2 could not commit them-
iate, were executed. Time independency of relative risks (RRs) selves to assessments every 3 months, 24 did not meet
was checked. Between-group differences for outcome mea- the inclusion criteria (14 had no BPD diagnosis, 1 had
sures were examined using end point analyses and by analyz- an anorexia nervosa diagnosis that became life-
ing the slopes of linear trend scores across all assessments dur- threatening during the screening procedure and re-
ing the 3 years because all linear trends on outcome measures quired immediate longer-term hospitalization, 1 was 17
differed significantly from zero in both conditions (Wilcoxon years old, and 8 had BPDSI-IV scores ⬍20), and 19 met
z⬎1.97; P⬍.05), except for DSQ–mature defenses (SFT: P=.90; the exclusion criteria (6 had bipolar disorder, 1 had psy-
TFP: P= .50). Therefore, outcome measures assessed every 3
chotic disorder, 1 had valium addiction and refused de-
(or 6) months were first transformed into linear trend scores,
representing the linear change of these measures (except DSQ– toxification, 2 had dissociative identity disorder, 7 had
mature defenses) during the 3-year study. antisocial personality disorder, and 2 had attention-
Heteroscedasticity, skewness of distributions, regression out- deficit/hyperactivity disorder). Eighty-eight patients
liers, and leverage point analyses revealed that assumptions for (50.9%) participated in the study. Primary and second-
parametric tests were not met. Robust analyses of covariance ary outcome variables and sociodemographic character-
were, therefore, used, with pretest as the covariate, using Wil- istics did not differ significantly among treatment cen-
cox analysis of covariance (ANCOVA) on medians.52,53 All the ters. One SFT patient and 1 TFP patient were excluded
tests were interpreted with a significance level of 5%. Analyses from the analyses; the SFT patient’s poor eyesight made
were performed using SPSS version 11.5 for Windows (SPSS assessments unreliable, and the TFP patient became un-
Inc, Chicago, Ill) (survival analyses, within-group analyses, and
traceable after randomization.
2 tests) and the Rplus (R Foundation for Statistical Comput-
ing, Vienna, Austria; http://www.r-project.org/) and Rallfun Six (13.6%) of 44 SFT patients and 2 (4.8%) of 42 TFP
(Rand R. Wilcox, Department of Psychology, University of patients successfully terminated treatment within 3 years,
Southern California, Los Angeles; http:psychology.usc.edu/ only coded as such when patient and therapist agreed on
faculty_homepage.php?id=43) Package, version 2.0.0, with ex- termination. No treatment was terminated because the
tensions v1.v3 and v2.v3 (Wilcox ANCOVAs on medians). therapist thought the patient was ready to end or owing
Schema-Focused Transference-Focused
Therapy Group Psychotherapy Group P
(n = 44) (n = 42) Value
Age, mean (SD), y 31.70 (8.9) 29.45 (6.5) .15b
Women 40 (90.9) 40 (95.2) .43b
Education
Graduate/professional 6 (13.6) 4 (9.5)
College graduate 3 (6.8) 7 (16.7)
Some college 17 (38.6) 14 (33.3) .22b
High school graduate 5 (11.4) 10 (23.8)
Grades 7-11 13 (29.6) 7 (16.7)
Employment status
Housewife 8 (18.2) 5 (11.9)
Student 3 (6.8) 6 (14.3)
Employed 9 (20.5) 8 (19.0) .89b
Disability 17 (38.6) 17 (40.5)
Welfare 7 (15.9) 6 (14.3)
Psychotropic medication use at baseline 34 (77.3) 30 (71.4) .87b
Recent suicide planning, steps, or attemptsc 17 (38.6) 32 (76.2) .007d
Recent nonsuicidal self-injurye 21 (47.7) 24 (57.1) .09d
Meeting DSM-IV BPD criterion 5 31 (70.5) 33 (78.6) .39b
Childhood sexual abusef 31 (70.5) 26 (61.9) .40b
Childhood physical abusef 40 (90.9) 37 (88.1) .67b
Childhood emotional abuse or neglectf 42 (95.5) 37 (88.1) .21b
No. of Axis I diagnoses, mean (SE) [95% CI] 2.95 (0.23) [2.49-3.42] 2.40 (0.25) [1.89-2.92] .11g
No. of Axis II diagnoses (BPD included), mean (SE) [95% CI] 2.14 (0.18) [1.78-2.49] 2.05 (0.18) [1.68-2.42] .73g
No. of SCID II BPD criteria, mean (SE) [95% CI] 6.70 (0.16) [6.38-7.03] 7.12 (0.19) [6.72-7.52] .23g
No. of treatment modalities before baseline, mean (SE) [95% CI]h 3.00 (0.19) [2.61-3.39] 2.79 (0.20) [2.38-3.20] .45g
Abbreviations: BPD, borderline personality disorder; BPDSI-IV, Borderline Personality Disorder Severity Index, fourth version; CI, confidence interval;
SCID II PD, Structured Clinical Interview for DSM-IV Axis II Personality Disorders.
a
Data are given as number (percentage) except where otherwise indicated.
b
Based on the Pearson 2 test.
c
According to BPDSI-IV items 5.1 to 5.8 in the previous 3 months.
d
Based on the Mann-Whitney test.
e
According to BPDSI-IV items 5.11 to 5.13 in the previous 3 months.
f
Assessed using the structured childhood trauma interview.
g
Based on analysis of variance.
h
Range, 0 to 6; individual treatment, group treatment, family/couples therapy, daily medication, clinical treatment, and otherwise.
to refusal of assessments. Twenty-seven SFT patients cho- and personality pathology. Numbers of comorbid
(61.4%) and 19 TFP patients (45.2%) were still in treat- Axis I and Axis II disorders were equally distributed. A
ment after 3 years. So-called completer SFT patients (ter- recent history of automutilating was significantly differ-
minated treatment or still in treatment) had significant ent between groups but had no effect on BPDSI-IV treat-
fewer therapy sessions than completer TFP patients (me- ment outcome (P =.22).
dian: 189.5 vs 231.0; MSTS = 3.12; P = .002). When pa-
tients dropped out of treatment can be read from Figure 1 TREATMENT OUTCOMES
and Figure 2. No patient committed suicide. Survival
analyses on the attrition rates show that TFP patients have Results of the primary and secondary outcome mea-
a significantly larger risk of dropout than SFT patients sures are given in Table 2 and Figure 3. Significant
(Kaplan-Meier method; log-rank statistic = 6.15; P =.01) effects after 3 years of SFT or TFP emerged for patients’
(Figure 2). The SFT dropout patients had significantly reduction of BPDSI scores (SFT: MSTS=−9.81, P⬍.001,
more sessions than TFP dropout patients (median: 98 vs Cohen d = 2.96; TFP: MSTS = −5.99, P⬍.001, d = 1.85),
34; MSTS=3.53; P⬍.001). improvement in quality of life (EuroQol thermometer
score: SFT:MSTS = 6.09, P = .001, d = 1.84; TFP:
TREATMENT GROUPS AT BASELINE MSTS = 2.06, P = .044, d = 0.64; WHOQOL total score:
SFT:MSTS = 4.86, P⬍.001, d = 1.46; TFP:MSTS = 3.73,
Table 1 gives an overview of patients’ characteristics in P⬍.001, d=1.16), and reduction in psycho- and person-
both conditions at baseline. Age, sex, educational level, ality pathology (SFT: MSTS = −6.73, P⬍.001, d = 2.02;
employment status, and psychotropic medication use did TFP: MSTS = −2.75, P⬍.006, d = 0.84). Both SFT and
not differ significantly between treatment groups. Pa- TFP patients improved significantly on all DSM-IV BPD
tients were mainly women in their 20s and 30s with criteria (P⬍.001 on all the BPDSI-IV subscales)
average educational levels. The treatment groups had simi- (Figure 4). All effects were already apparent after
lar levels of BPD abnormality, quality of life, and psy- 1 year.
Abbreviations: ANCOVA, analysis of covariance; BPDSI-IV, Borderline Personality Disorder Severity Index, fourth version; CI, confidence interval;
WHOQOL, World Health Organization quality of life assessment.
a
Data are given as median (SE) [95% CI] except where otherwise indicated. Yearly assessments instead of assessments every 3 months are depicted to save space.
b
Based on the Pearson 2 test.
c
Higher scores indicate more severe borderline personality disorder abnormalities.
d
Based on Wilcox ANCOVA: robust ANCOVA39,40 based on Wilcox Rallfun package (Rand R. Wilcox, Department of Psychology, University of Southern California,
Los Angeles; www-rfc.usc.edu/~rwilcox/).
e
Linear trend Wilcox ANCOVA on medians on 13 assessments (psycho- and personality pathology, 7 assessments).
f
End point Wilcox ANCOVA on medians.
g
Higher scores indicate higher levels of quality of life.
h
Higher scores indicate more psycho- and personality pathology.
13
BPDSI-IV Total Score
35
30
12 statistic=3.88; P=.049; RR=2.15; 95% confidence inter-
11 val [CI], 1.00-4.59); baseline BPDSI-IV was not signifi-
25
10
20 SFT
cant (P=.38) (Figure 4). Without baseline BPDSI-IV, the
9
15 8 TFP group effect was comparable (Wald statistic=4.04; P=.04;
10 7
RR=2.18; 95% CI, 1.02-4.66). Differential dropout can
1 3 5 7 9 11 13 1 3 5 7 9 11 13 only partly explain the difference between treatments be-
Month Month
cause survival analysis with dropout status as an addi-
tional covariate was not significant for dropout, and the
C D group effect became nonsignificant, although still in the
80 0.8
EuroQol Thermometer Score
0.6
70 RR=1.91; 95% CI, 0.88-4.14 and dropout Wald=1.90;
Psychopathology
0.4
60 0.2 P =.17; RR=1.84; 95% CI, 0.77-4.35). The group effect
50
0 persisted when the analysis was adjusted for the use of
–0.2
–0.4
psychotropic medication as a time-dependent covariate
40
–0.6 (13 assessments; Wald statistic=4.42; P=.04; RR=2.26;
30 –0.8 95% CI, 1.06-4.85). Baseline BPDSI-IV was not signifi-
1 3 5 7 9 11 13 Baseline 1 2 3
Month Year cant (P=.33). Psychotropic medication use had a signifi-
cant negative effect on recovery (Wald statistic = 6.21;
Figure 3. Median primary and secondary outcome measure scores.
P=.01; RR=0.38; 95% CI, 0.18-0.81): 55% of patients who
A, Borderline Personality Disorder Severity Index, fourth version (BPDSI-IV) did not use medication at the start recovered compared
total scores (range, 0-90). B, World Health Organization quality of life with 28% of those using medication. The treatment
assessment (WHOQOL) total scores (range, 4-20). C, EuroQol thermometer group⫻medication interaction was not significant. Pa-
scores (range, 0-100). D, Composite psycho- and personality pathology
factor scores. SFT indicates schema-focused therapy; TFP, transference- tient use of psychotropic medications across time is shown
focused psychotherapy. in Figure 5. In addition, 1 TFP patient started taking a
0.9 0.9
0.8 0.8
0.6 0.6
0.5 0.5
0.4 0.4
0.3 0.3
0.2 0.2
0.1 0.1
–0.1 –0.1
0 2 4 6 8 10 12 14 0 2 4 6 8 10 12 14
Assessment Assessment
Figure 4. Proportion of patients recovered (A) and reliably changed (B) for transference-focused psychotherapy (TFP) and schema-focused therapy (SFT),
adjusted for baseline Borderline Personality Disorder Severity Index, fourth version, score.
Abandonment Score
2.5 5
3.5
3.0 2.0 4
2.5
1.5 3
2.0
1.5 1.0 2
1.0
0.5 1
0.5
0 0 0
1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13
Month Month Month
D E F
2.0 1.5 8.0
Parasuicidality Score
1.6 1.2
Impulsivity Score
7.0
1.2 0.9 6.5
6.0
0.8 0.6 5.5
5.0
0.4 0.3
4.5
0 0 4.0
1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13
Month Month Month
G H I
7.0 3.5 3.0
6.0
Ideation Score
2.5
Anger Score
5.5 2.0
2.0
5.0 1.5
1.5
4.5 1.0
4.0 1.0
3.5 0.5 0.5
3.0 0 0
1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13
Month Month Month
Figure 6. Median Borderline Personality Disorder Severity Index, fourth version (BPDSI-IV), subscale scores: abandonment (A), unstable relationships (B),
identity disturbance (C), impulsivity (D), parasuicidality (E), affective instability (F), emptiness (G), anger (H), and paranoid and dissociative ideation (I).
SFT indicates schema-focused therapy; TFP, transference-focused psychotherapy.
Correction
Errors in Table and Figure. In the Original Article by Giesen-Bloo et al titled “Outpatient Psychotherapy for Borderline
Personality Disorder: Randomized Trial of Schema-Focused Therapy vs Transference-Focused Psychotherapy,” pub-
lished in the June issue of the ARCHIVES (2006;63:649-658), there were several errors in Table 1. The table is reprinted
correctly as follows. Furthermore, neither recent suicide planning, steps, or attempts nor recent nonsuicidal self-injury
were significantly related to recovery from borderline personality disorder or changed the difference between schema-
focused therapy and transference-focused psychotherapy when these variables were entered alone or in combination in
the survival analyses. In all analyses, schema-focused therapy remained superior to transference-focused psychotherapy.
Treatment group by suicidal or self-injury manifestation interaction was not significant. In addition, the x-axis label in
Figure 3A, B, and C should have been “Assessment” rather than “Month.” The ARCHIVES regrets these errors.
Schema-Focused Transference-Focused
Therapy Group Psychotherapy Group P
(n = 44) (n = 42) Value
Age, mean (SD), y 31.70 (8.89) 29.45 (6.47) .15b
Women 40 (90.9) 40 (95.2) .43b
Education
Graduate/professional 6 (13.6) 4 (9.5)
College graduate 3 (6.8) 7 (16.7)
Some college 17 (38.6) 14 (33.3) .22b
High school graduate 5 (11.4) 10 (23.8)
Grades 7-11 13 (29.6) 7 (16.7)
Employment status
Housewife 8 (18.2) 5 (11.9)
Student 3 (6.8) 6 (14.3)
Employed 9 (20.5) 8 (19.0) .89b
Disability 17 (38.6) 17 (40.5)
Welfare 7 (15.9) 6 (14.3)
Psychotropic medication use at baseline 34 (77.3) 30 (71.4) .87b
Recent suicide planning, steps, or attemptsc 17 (38.6) 24 (57.1) .09b
Recent nonsuicidal self-injuryd 21 (47.7) 32 (76.2) .007b
Meeting DSM-IV BPD criterion 5 31 (70.5) 33 (78.6) .39b
Childhood sexual abusee 31 (70.5) 26 (61.9) .40b
Childhood physical abusee 40 (90.9) 37 (88.1) .67b
Childhood emotional abuse or neglecte 42 (95.5) 37 (88.1) .21b
No. of Axis I diagnoses, mean (SE) [95% CI] 2.95 (0.23) [2.49-3.42] 2.40 (0.25) [1.89-2.92] .11f
No. of Axis II diagnoses (BPD included), mean (SE) [95% CI] 2.14 (0.18) [1.78-2.49] 2.05 (0.18) [1.68-2.42] .73f
No. of SCID II BPD criteria, mean (SE) [95% CI] 6.70 (0.16) [6.38-7.03] 7.12 (0.19) [6.72-7.52] .23f
No. of treatment modalities before baseline, mean (SE) [95% CI]g 3.00 (0.19) [2.61-3.39] 2.79 (0.20) [2.38-3.20] .45f
Abbreviations: BPD, borderline personality disorder; BPDSI-IV, Borderline Personality Disorder Severity Index, fourth version; CI, confidence
interval; SCID II PD, Structured Clinical Interview for DSM-IV Axis II Personality Disorders.
a
Data are given as number (percentage) except where otherwise indicated.
b
Based on the Pearson 2 test.
c
According to BPDSI-IV items 5.11 to 5.13 in the previous 3 mo.
d
According to BPDSI-IV items 5.1 to 5.8 in the previous 3 mo.
e
Assessed using the structured childhood trauma interview.
f
Based on analysis of variance.
g
Range, 0 to 6; individual treatment, group treatment, family/couples therapy, daily medication, clinical treatment, and otherwise.